← Open Payments lookup

JOHANNA TANIGUCHI: Open Payments

NPI 1770936676 · SEATTLE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$945 in 33 payments from 13 companies in 2025. Trend: 2023 $341 · 2024 $961 · 2025 $945

Food & beverage: $945
CompanyPaymentsAmount
ABBVIE INC.6$280
GENZYME CORPORATION2$148
PFIZER INC.6$112
Phathom Pharmaceuticals, Inc.6$107
Takeda Pharmaceuticals U.S.A., Inc.3$93
Salix Pharmaceuticals, a division of Bausch Health US, LLC3$73
Janssen Biotech, Inc.1$22
Ardelyx, Inc.1$21
Regeneron Healthcare Solutions, Inc.1$21
Madrigal Pharmaceuticals1$21

Products named: SKYRIZI, DUPIXENT, VOQUEZNA, ENTYVIO, XELJANZ, XIFAXAN, VELSIPITY, CREON.

Industry payments across WA — which companies pay providers there.